Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-19
DOI
10.3389/fimmu.2021.645839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
- (2021) José María Piulats et al. JOURNAL OF CLINICAL ONCOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
- (2021) Jialin Meng et al. Molecular Therapy-Oncolytics
- Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
- (2021) Xingyu Chen et al. Frontiers in Immunology
- Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer
- (2021) Xingyu Chen et al. Frontiers in Oncology
- Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
- (2021) Arjun V Balar et al. LANCET ONCOLOGY
- Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis
- (2020) Mi Li et al. BMC CANCER
- Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
- (2020) Allison Betof Warner et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response
- (2020) Lin Huan et al. Molecular Cancer
- Interferon gamma inhibits CXCL8–CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer
- (2020) Mingjie Zhang et al. Journal for ImmunoTherapy of Cancer
- A 15-gene immune, stromal and proliferation gene signature that significantly associates with poor survival in patients with pancreatic ductal adenocarcinoma
- (2020) Raju Kandimalla et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
- (2020) Dmitriy Zamarin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response
- (2020) Xinghuo Li et al. LEUKEMIA
- Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
- (2020) Alejandro Jiménez-Sánchez et al. NATURE GENETICS
- Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma
- (2020) Alexandra Garancher et al. NATURE NEUROSCIENCE
- SLC1A1, SLC16A9, and CNTN3 Are Potential Biomarkers for the Occurrence of Colorectal Cancer
- (2020) Jie Zhou et al. Biomed Research International
- Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups
- (2020) Wanzun Lin et al. Frontiers in Oncology
- Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
- (2020) Luisa F. Escobar-Hoyos et al. CANCER CELL
- Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
- (2020) Zhi-Ling Li et al. Nature Communications
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
- (2020) Catherine S. Grasso et al. CANCER CELL
- Functional genomic landscape of cancer-intrinsic evasion of killing by T cells
- (2020) Keith A. Lawson et al. NATURE
- Cancer immunotherapy via targeted TGF-β signalling blockade in TH cells
- (2020) Shun Li et al. NATURE
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma
- (2020) Thomas Powles et al. NEW ENGLAND JOURNAL OF MEDICINE
- HIF-2α is indispensable for regulatory T cell function
- (2020) Tzu-Sheng Hsu et al. Nature Communications
- Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
- (2020) Grégoire de Streel et al. Nature Communications
- Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
- (2020) Youqiong Ye et al. Genome Medicine
- Immune response drives outcomes in prostate cancer: implications for immunotherapy
- (2020) Jialin Meng et al. Molecular Oncology
- Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer
- (2020) Emese Zsiros et al. JAMA Oncology
- Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
- (2019) Stefano Annunziato et al. Nature Communications
- Blocking TREM-1+ Tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-PD-L1 resistance in liver cancer
- (2019) Qinchuan Wu et al. HEPATOLOGY
- Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer
- (2019) Yi Xiao et al. CLINICAL CANCER RESEARCH
- Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study
- (2019) U A Matulonis et al. ANNALS OF ONCOLOGY
- Anti-tumor effects of anti-Semaphorin 4D antibody unravel a novel pro-invasive mechanism of vascular targeting agents
- (2019) Iratxe Zuazo-Gaztelu et al. CANCER RESEARCH
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
- (2019) Krishnansu S. Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment
- (2019) Fan Wang et al. CANCER BIOLOGY & THERAPY
- Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
- (2019) Alberto Carmona-Bayonas et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
- (2019) Youngjin Han et al. ONCOGENE
- Immunity, Hypoxia and Metabolism - the ménage à trois of cancer: implications for immunotherapy
- (2019) Carla Riera-Domingo et al. PHYSIOLOGICAL REVIEWS
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
- (2019) Yang Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
- (2018) Allen W. Zhang et al. CELL
- LAG-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells
- (2018) Andreia C. Lino et al. IMMUNITY
- Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal
- (2018) Shi-Yi Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- Determinants and clinical implications of chromosomal instability in cancer
- (2018) Laurent Sansregret et al. Nature Reviews Clinical Oncology
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma
- (2018) Jeong-Sun Seo et al. Cancer Immunology Research
- CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma
- (2018) Long-Zi Liu et al. HEPATOLOGY
- Copy number signatures and mutational processes in ovarian carcinoma
- (2018) Geoff Macintyre et al. NATURE GENETICS
- Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
- (2018) Peng Jiang et al. NATURE MEDICINE
- Effects of tumor metabolic microenvironment on regulatory T cells
- (2018) Yi-an Wang et al. Molecular Cancer
- Imidazo[1,2-b]pyrazole-7-carboxamides Induce Apoptosis in Human Leukemia Cells at Nanomolar Concentrations
- (2018) Gábor Szebeni et al. MOLECULES
- Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
- (2018) Ying Wen et al. ONCOGENE
- Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
- (2018) Monica Parodi et al. Frontiers in Immunology
- Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype
- (2018) Yao Xiao et al. CANCER LETTERS
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
- (2017) Guoying Zhou et al. GASTROENTEROLOGY
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
- (2017) Whijae Roh et al. Science Translational Medicine
- Alternative activation generates IL-10 producing type 2 innate lymphoid cells
- (2017) Corey R. Seehus et al. Nature Communications
- Oleuropein represses the radiation resistance of ovarian cancer by inhibiting hypoxia and microRNA-299-targetted heparanase expression
- (2017) Yubai Xing et al. Food & Function
- Development and Validation of a Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Colorectal Cancer
- (2016) Yan-qi Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- A hypoxia-responsive TRAF6–ATM–H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis
- (2016) Abdol-Hossein Rezaeian et al. NATURE CELL BIOLOGY
- Bioinformatic profiling identifies an immune-related risk signature for glioblastoma
- (2016) Wen Cheng et al. NEUROLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- SREBP maintains lipid biosynthesis and viability of cancer cells under lipid- and oxygen-deprived conditions and defines a gene signature associated with poor survival in glioblastoma multiforme
- (2015) C A Lewis et al. ONCOGENE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas
- (2014) Shaomei Cheng et al. TUMOR BIOLOGY
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- Prognostic Value of a Nine-Gene Signature in Glioma Patients Based on mRNA Expression Profiling
- (2013) Zhao-Shi Bao et al. CNS Neuroscience & Therapeutics
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- An 18-gene signature (ColoPrint®) for colon cancer prognosis
- (2011) Iain B. Tan et al. Nature Reviews Clinical Oncology
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
- (2010) Gemma Molyneux et al. Cell Stem Cell
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
- Polo-like Kinase 3 Functions as a Tumor Suppressor and Is a Negative Regulator of Hypoxia-Inducible Factor-1 under Hypoxic Conditions
- (2008) Y. Yang et al. CANCER RESEARCH
- How To Build and Interpret a Nomogram for Cancer Prognosis
- (2008) Alexia Iasonos et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now